Project Details
| Status | Active |
|---|---|
| Effective start/end date | 23/07/26 → 22/07/28 |
Keywords
- clinical trials
- SAR448851
- ACT23645
- Alzheimer’s disease
Clinical Trial Phase
- Phase II
A Phase 2, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of 48-week SAR448851 treatment followed by open-label extension in participants with early Alzheimer’s disease
- Darby, David (Primary Chief Investigator (PCI))
Project: Research